Hypofractionated Radiotherapy in Intermediate-Risk Prostate Cancer Patients: Long-Term Results

Hypofractionated Radiotherapy in Intermediate-Risk Prostate Cancer Patients: Long-Term Results

Background: To evaluate outcomes in terms of survival and toxicity in a series of intermediate-risk prostate cancer (PCa) patients treated with hypofractionated radiotherapy (HyRT) + hormonal therapy (HT) with or without image guidance (IGRT) and to investigate the impact of different variables. Met...

Full description

Bibliographic Details
Main Authors: Maurizio Valeriani, Mario Di Staso, Giuseppe Facondo, Gianluca Vullo, Vitaliana De Sanctis, Giovanni Luca Gravina, Milena di Genesio Pagliuca, Mattia Falchetto Osti, Pierluigi Bonfili
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Journal of Clinical Medicine
Subjects:
intermediate-risk prostate cancer
hypofractionated radiotherapy
prognostic factors
3D-CRT
PSA
Online Access:https://www.mdpi.com/2077-0383/11/16/4783

Internet

https://www.mdpi.com/2077-0383/11/16/4783

Similar Items